[
    {
        "id": 3638,
        "drug_name": "NexoBrid",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Severe burns",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-06-29",
        "link": "https:\/\/www.benzinga.com\/pressreleases\/21\/06\/g21764139\/mediwound-receives-complete-response-letter-from-u-s-fda-for-nexobrid-biologics-license-applicatio",
        "note": "CRL announced June 29, 2021.",
        "company_entity_id": 194,
        "company_ticker": "MDWD",
        "company_name": "MediWound Ltd.",
        "company_price": "13.4000",
        "company_change": 0.14,
        "company_percent_change": 1.06,
        "company_optionable": 1,
        "company_number_of_shares": 7240020,
        "price_change_sparkline": [
            [
                11.25,
                1704171600
            ],
            [
                11.95,
                1704258000
            ],
            [
                11.69,
                1704344400
            ],
            [
                11.47,
                1704430800
            ],
            [
                11.82,
                1704690000
            ],
            [
                12.49,
                1704776400
            ],
            [
                12.48,
                1704862800
            ],
            [
                12.83,
                1704949200
            ],
            [
                12.65,
                1705035600
            ],
            [
                12.87,
                1705381200
            ],
            [
                12.95,
                1705467600
            ],
            [
                13.02,
                1705554000
            ],
            [
                13,
                1705640400
            ],
            [
                13.49,
                1705899600
            ],
            [
                13.05,
                1705986000
            ],
            [
                12.99,
                1706072400
            ],
            [
                12.88,
                1706158800
            ],
            [
                12.8,
                1706245200
            ],
            [
                12.89,
                1706504400
            ],
            [
                12.86,
                1706590800
            ],
            [
                12.77,
                1706677200
            ],
            [
                12.67,
                1706763600
            ],
            [
                12.32,
                1706850000
            ],
            [
                11.25,
                1707109200
            ],
            [
                11.27,
                1707195600
            ],
            [
                12.16,
                1707282000
            ],
            [
                12.14,
                1707368400
            ],
            [
                11.9,
                1707454800
            ],
            [
                12.46,
                1707714000
            ],
            [
                12.73,
                1707800400
            ],
            [
                12.74,
                1707886800
            ],
            [
                13.08,
                1707973200
            ],
            [
                13.07,
                1708059600
            ],
            [
                13.12,
                1708405200
            ],
            [
                13.25,
                1708491600
            ],
            [
                13.26,
                1708578000
            ],
            [
                13.4,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 7369,
        "drug_name": "Retifanlimab",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Squamous Cell Carcinoma of the Anal Canal (SCAC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-07-23",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210723005449\/en\/",
        "note": "CRL announced July 23, 2021",
        "company_entity_id": 167,
        "company_ticker": "INCY",
        "company_name": "Incyte Corporation",
        "company_price": "60.5900",
        "company_change": -0.31999999999999995,
        "company_percent_change": -0.53,
        "company_optionable": 1,
        "company_number_of_shares": 224526128,
        "price_change_sparkline": [
            [
                65.45,
                1704171600
            ],
            [
                65.51,
                1704258000
            ],
            [
                66.59,
                1704344400
            ],
            [
                65.26,
                1704430800
            ],
            [
                65.82,
                1704690000
            ],
            [
                64.38,
                1704776400
            ],
            [
                64.14,
                1704862800
            ],
            [
                63.11,
                1704949200
            ],
            [
                62.74,
                1705035600
            ],
            [
                61.34,
                1705381200
            ],
            [
                61.48,
                1705467600
            ],
            [
                61.18,
                1705554000
            ],
            [
                61.49,
                1705640400
            ],
            [
                61.5,
                1705899600
            ],
            [
                61.87,
                1705986000
            ],
            [
                60.84,
                1706072400
            ],
            [
                60.92,
                1706158800
            ],
            [
                60.64,
                1706245200
            ],
            [
                60.47,
                1706504400
            ],
            [
                59.28,
                1706590800
            ],
            [
                58.77,
                1706677200
            ],
            [
                59.16,
                1706763600
            ],
            [
                58.35,
                1706850000
            ],
            [
                58.06,
                1707109200
            ],
            [
                59.63,
                1707195600
            ],
            [
                57.34,
                1707282000
            ],
            [
                57.36,
                1707368400
            ],
            [
                57.66,
                1707454800
            ],
            [
                57.84,
                1707714000
            ],
            [
                59.34,
                1707800400
            ],
            [
                57.89,
                1707886800
            ],
            [
                58.97,
                1707973200
            ],
            [
                57.96,
                1708059600
            ],
            [
                58.82,
                1708405200
            ],
            [
                60.33,
                1708491600
            ],
            [
                60.91,
                1708578000
            ],
            [
                60.59,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2450,
        "drug_name": "Roxadustat",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Anaemia in Chronic Kidney Disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-08-11",
        "link": "https:\/\/fibrogen.gcs-web.com\/news-releases\/news-release-details\/fibrogen-receives-complete-response-letter-fda-roxadustat-anemia",
        "note": "CRL announced August 11, 2021.",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "65.8300",
        "company_change": 1.7,
        "company_percent_change": 2.65,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                67.3653075328265,
                1704171600
            ],
            [
                67.2865176994548,
                1704258000
            ],
            [
                67.7395592413422,
                1704344400
            ],
            [
                67.3456100744836,
                1704430800
            ],
            [
                68.1630545957153,
                1704690000
            ],
            [
                67.8675927205713,
                1704776400
            ],
            [
                68.517608845888,
                1704862800
            ],
            [
                68.1335084082009,
                1704949200
            ],
            [
                68.3698779083161,
                1705035600
            ],
            [
                66.2524011364509,
                1705381200
            ],
            [
                65.2478307609614,
                1705467600
            ],
            [
                65.513746448591,
                1705554000
            ],
            [
                65.5334439069339,
                1705640400
            ],
            [
                66.1243676572218,
                1705899600
            ],
            [
                65.7402672195347,
                1705986000
            ],
            [
                65.5925362819627,
                1706072400
            ],
            [
                66.0061829071642,
                1706158800
            ],
            [
                66.084972740536,
                1706245200
            ],
            [
                66.1736113030792,
                1706504400
            ],
            [
                66.1834600322506,
                1706590800
            ],
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2450,
        "drug_name": "Roxadustat",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Anaemia in Chronic Kidney Disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-08-11",
        "link": "https:\/\/fibrogen.gcs-web.com\/news-releases\/news-release-details\/fibrogen-receives-complete-response-letter-fda-roxadustat-anemia",
        "note": "CRL announced August 11, 2021.",
        "company_entity_id": 142,
        "company_ticker": "FGEN",
        "company_name": "FibroGen Inc",
        "company_price": "1.8200",
        "company_change": -0.06999999999999995,
        "company_percent_change": -3.7,
        "company_optionable": 1,
        "company_number_of_shares": 98340219,
        "price_change_sparkline": [
            [
                0.8306,
                1704171600
            ],
            [
                0.7947,
                1704258000
            ],
            [
                0.7336,
                1704344400
            ],
            [
                0.75,
                1704430800
            ],
            [
                0.7849,
                1704690000
            ],
            [
                0.9018,
                1704776400
            ],
            [
                0.8449,
                1704862800
            ],
            [
                0.8132,
                1704949200
            ],
            [
                0.7526,
                1705035600
            ],
            [
                0.7625,
                1705381200
            ],
            [
                0.75,
                1705467600
            ],
            [
                0.7948,
                1705554000
            ],
            [
                0.7625,
                1705640400
            ],
            [
                0.8785,
                1705899600
            ],
            [
                0.8925,
                1705986000
            ],
            [
                0.9703,
                1706072400
            ],
            [
                1.1,
                1706158800
            ],
            [
                0.9359,
                1706245200
            ],
            [
                1.71,
                1706504400
            ],
            [
                1.72,
                1706590800
            ],
            [
                1.92,
                1706677200
            ],
            [
                2.37,
                1706763600
            ],
            [
                1.86,
                1706850000
            ],
            [
                2.025,
                1707109200
            ],
            [
                1.91,
                1707195600
            ],
            [
                2.17,
                1707282000
            ],
            [
                2.38,
                1707368400
            ],
            [
                2.73,
                1707454800
            ],
            [
                2.72,
                1707714000
            ],
            [
                2.17,
                1707800400
            ],
            [
                2.25,
                1707886800
            ],
            [
                2.15,
                1707973200
            ],
            [
                2.19,
                1708059600
            ],
            [
                1.8,
                1708405200
            ],
            [
                1.715,
                1708491600
            ],
            [
                1.89,
                1708578000
            ],
            [
                1.82,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3151,
        "drug_name": "Vicineum",
        "clinical_trial_id": "NCT02449239",
        "has_trial_insight_page": 0,
        "indication": "Non-muscle invasive bladder cancer (NMIBC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-08-13",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210813005377\/en\/",
        "note": "CRL announced August 13, 2021.",
        "company_entity_id": 2348,
        "company_ticker": "CARM",
        "company_name": "Carisma Therapeutics Inc.",
        "company_price": "2.4200",
        "company_change": -0.06000000000000005,
        "company_percent_change": -2.42,
        "company_optionable": 0,
        "company_number_of_shares": 40356806,
        "price_change_sparkline": [
            [
                2.84,
                1704171600
            ],
            [
                2.79,
                1704258000
            ],
            [
                2.73,
                1704344400
            ],
            [
                2.63,
                1704430800
            ],
            [
                2.88,
                1704690000
            ],
            [
                2.79,
                1704776400
            ],
            [
                2.76,
                1704862800
            ],
            [
                2.6,
                1704949200
            ],
            [
                2.59,
                1705035600
            ],
            [
                2.39,
                1705381200
            ],
            [
                2.38,
                1705467600
            ],
            [
                2.35,
                1705554000
            ],
            [
                2.29,
                1705640400
            ],
            [
                2.45,
                1705899600
            ],
            [
                2.37,
                1705986000
            ],
            [
                2.3,
                1706072400
            ],
            [
                2.21,
                1706158800
            ],
            [
                2.15,
                1706245200
            ],
            [
                2.34,
                1706504400
            ],
            [
                2.2,
                1706590800
            ],
            [
                2.1,
                1706677200
            ],
            [
                2.16,
                1706763600
            ],
            [
                2.14,
                1706850000
            ],
            [
                2.05,
                1707109200
            ],
            [
                2.1,
                1707195600
            ],
            [
                2.01,
                1707282000
            ],
            [
                2.1,
                1707368400
            ],
            [
                2.11,
                1707454800
            ],
            [
                2.26,
                1707714000
            ],
            [
                2.07,
                1707800400
            ],
            [
                2.13,
                1707886800
            ],
            [
                2.29,
                1707973200
            ],
            [
                2.3,
                1708059600
            ],
            [
                2.41,
                1708405200
            ],
            [
                2.45,
                1708491600
            ],
            [
                2.48,
                1708578000
            ],
            [
                2.42,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2283,
        "drug_name": "Narsoplimab",
        "clinical_trial_id": "NCT04247906",
        "has_trial_insight_page": 0,
        "indication": "Hematopoietic stem cell-associated TMA (HSCT-TMA)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-10-18",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20211018005335\/en\/",
        "note": "CRL announced October 18, 2021.",
        "company_entity_id": 226,
        "company_ticker": "OMER",
        "company_name": "Omeros Corporation",
        "company_price": "4.1200",
        "company_change": -0.040000000000000036,
        "company_percent_change": -0.84,
        "company_optionable": 1,
        "company_number_of_shares": 62865491,
        "price_change_sparkline": [
            [
                3.29,
                1704171600
            ],
            [
                2.88,
                1704258000
            ],
            [
                3.03,
                1704344400
            ],
            [
                3.06,
                1704430800
            ],
            [
                3.57,
                1704690000
            ],
            [
                3.95,
                1704776400
            ],
            [
                3.74,
                1704862800
            ],
            [
                3.69,
                1704949200
            ],
            [
                3.53,
                1705035600
            ],
            [
                3.48,
                1705381200
            ],
            [
                3.88,
                1705467600
            ],
            [
                3.87,
                1705554000
            ],
            [
                3.89,
                1705640400
            ],
            [
                3.59,
                1705899600
            ],
            [
                3.41,
                1705986000
            ],
            [
                3.455,
                1706072400
            ],
            [
                3.35,
                1706158800
            ],
            [
                3.29,
                1706245200
            ],
            [
                3.35,
                1706504400
            ],
            [
                3.28,
                1706590800
            ],
            [
                3.24,
                1706677200
            ],
            [
                3.4,
                1706763600
            ],
            [
                3.4,
                1706850000
            ],
            [
                3.28,
                1707109200
            ],
            [
                3.35,
                1707195600
            ],
            [
                3.29,
                1707282000
            ],
            [
                3.31,
                1707368400
            ],
            [
                3.82,
                1707454800
            ],
            [
                3.915,
                1707714000
            ],
            [
                3.63,
                1707800400
            ],
            [
                4.58,
                1707886800
            ],
            [
                4.89,
                1707973200
            ],
            [
                4.89,
                1708059600
            ],
            [
                4.66,
                1708405200
            ],
            [
                4.24,
                1708491600
            ],
            [
                4.155,
                1708578000
            ],
            [
                4.12,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4422,
        "drug_name": "Plinabulin + G-CSF Combination - (PROTECTIVE 2)",
        "clinical_trial_id": "NCT03294577",
        "has_trial_insight_page": 0,
        "indication": "Chemotherapy-induced neutropenia (CIN)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-12-01",
        "link": "https:\/\/www.globenewswire.com\/news-release\/2021\/12\/01\/2344069\/0\/en\/BeyondSpring-Pharmaceuticals-Receives-Complete-Response-Letter-from-the-FDA-for-Plinabulin-New-Drug-Application-for-Prevention-of-Chemotherapy-Induced-Neutropenia-CIN.html",
        "note": "CRL announced December 1, 2021.",
        "company_entity_id": 406,
        "company_ticker": "BYSI",
        "company_name": "BeyondSpring Inc.",
        "company_price": "1.0900",
        "company_change": 0.02,
        "company_percent_change": 1.87,
        "company_optionable": 1,
        "company_number_of_shares": 38920000,
        "price_change_sparkline": [
            [
                0.856,
                1704171600
            ],
            [
                0.89,
                1704258000
            ],
            [
                0.9,
                1704344400
            ],
            [
                0.93,
                1704430800
            ],
            [
                0.9375,
                1704690000
            ],
            [
                0.888,
                1704776400
            ],
            [
                0.9001,
                1704862800
            ],
            [
                0.850201,
                1704949200
            ],
            [
                0.88,
                1705035600
            ],
            [
                0.8767,
                1705381200
            ],
            [
                0.8528,
                1705467600
            ],
            [
                0.9,
                1705554000
            ],
            [
                0.88,
                1705640400
            ],
            [
                0.866,
                1705899600
            ],
            [
                0.898,
                1705986000
            ],
            [
                0.9,
                1706072400
            ],
            [
                0.8901,
                1706158800
            ],
            [
                0.9102,
                1706245200
            ],
            [
                0.98,
                1706504400
            ],
            [
                0.97,
                1706590800
            ],
            [
                0.98,
                1706677200
            ],
            [
                1,
                1706763600
            ],
            [
                1,
                1706850000
            ],
            [
                1.06,
                1707109200
            ],
            [
                1.04,
                1707195600
            ],
            [
                1.1,
                1707282000
            ],
            [
                1.145,
                1707368400
            ],
            [
                1.49,
                1707454800
            ],
            [
                1.35,
                1707714000
            ],
            [
                1.37,
                1707800400
            ],
            [
                1.39,
                1707886800
            ],
            [
                1.37,
                1707973200
            ],
            [
                1.33,
                1708059600
            ],
            [
                1.18,
                1708405200
            ],
            [
                1.16,
                1708491600
            ],
            [
                1.07,
                1708578000
            ],
            [
                1.09,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 7113,
        "drug_name": "TAK-721",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Eosinophilic esophagitis",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-12-21",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20211221005772\/en\/",
        "note": "CRL December 21, 2021.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.6200",
        "company_change": -0.020000000000000018,
        "company_percent_change": -0.14,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.34,
                1704171600
            ],
            [
                14.34,
                1704258000
            ],
            [
                14.55,
                1704344400
            ],
            [
                14.72,
                1704430800
            ],
            [
                14.83,
                1704690000
            ],
            [
                14.76,
                1704776400
            ],
            [
                14.88,
                1704862800
            ],
            [
                14.93,
                1704949200
            ],
            [
                15.04,
                1705035600
            ],
            [
                15.01,
                1705381200
            ],
            [
                14.86,
                1705467600
            ],
            [
                14.87,
                1705554000
            ],
            [
                14.71,
                1705640400
            ],
            [
                14.79,
                1705899600
            ],
            [
                14.73,
                1705986000
            ],
            [
                14.68,
                1706072400
            ],
            [
                14.63,
                1706158800
            ],
            [
                14.6,
                1706245200
            ],
            [
                14.77,
                1706504400
            ],
            [
                14.54,
                1706590800
            ],
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5352,
        "drug_name": "Intravenous (IV) tramadol",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Postoperative pain following bunionectomy surgery",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-02-15",
        "link": "https:\/\/www.youtube.com\/watch?v=9O0a5fyIoFc",
        "note": "FDA AdCom Meeting resulted in a 8-14 vote against the question that the application showed that benefits outweighs the risks, noted February 15, 2022.",
        "company_entity_id": 140,
        "company_ticker": "FBIO",
        "company_name": "Fortress Biotech Inc.",
        "company_price": "1.7400",
        "company_change": -0.010000000000000009,
        "company_percent_change": -0.5700000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 8942751,
        "price_change_sparkline": [
            [
                2.69,
                1704171600
            ],
            [
                2.48,
                1704258000
            ],
            [
                2.5,
                1704344400
            ],
            [
                2.42,
                1704430800
            ],
            [
                2.26,
                1704690000
            ],
            [
                2.12,
                1704776400
            ],
            [
                1.94,
                1704862800
            ],
            [
                1.86,
                1704949200
            ],
            [
                1.92,
                1705035600
            ],
            [
                1.81,
                1705381200
            ],
            [
                1.88,
                1705467600
            ],
            [
                1.84,
                1705554000
            ],
            [
                1.9,
                1705640400
            ],
            [
                1.99,
                1705899600
            ],
            [
                2,
                1705986000
            ],
            [
                2.01,
                1706072400
            ],
            [
                2.09,
                1706158800
            ],
            [
                2.06,
                1706245200
            ],
            [
                2.1,
                1706504400
            ],
            [
                2,
                1706590800
            ],
            [
                2.04,
                1706677200
            ],
            [
                1.97,
                1706763600
            ],
            [
                1.85,
                1706850000
            ],
            [
                1.72,
                1707109200
            ],
            [
                1.72,
                1707195600
            ],
            [
                1.75,
                1707282000
            ],
            [
                1.8,
                1707368400
            ],
            [
                1.87,
                1707454800
            ],
            [
                1.92,
                1707714000
            ],
            [
                1.77,
                1707800400
            ],
            [
                1.88,
                1707886800
            ],
            [
                1.88,
                1707973200
            ],
            [
                1.86,
                1708059600
            ],
            [
                1.78,
                1708405200
            ],
            [
                1.73,
                1708491600
            ],
            [
                1.75,
                1708578000
            ],
            [
                1.74,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5352,
        "drug_name": "Intravenous (IV) tramadol",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Postoperative pain following bunionectomy surgery",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-02-15",
        "link": "https:\/\/www.youtube.com\/watch?v=9O0a5fyIoFc",
        "note": "FDA AdCom Meeting resulted in a 8-14 vote against the question that the application showed that benefits outweighs the risks, noted February 15, 2022.",
        "company_entity_id": 470,
        "company_ticker": "ATXI",
        "company_name": "Avenue Therapeutics Inc.",
        "company_price": "0.1345",
        "company_change": -0.010000000000000009,
        "company_percent_change": -5.41,
        "company_optionable": 0,
        "company_number_of_shares": 13247622,
        "price_change_sparkline": [
            [
                0.16,
                1704171600
            ],
            [
                0.1749,
                1704258000
            ],
            [
                0.3423,
                1704344400
            ],
            [
                0.1895,
                1704430800
            ],
            [
                0.1949,
                1704690000
            ],
            [
                0.1885,
                1704776400
            ],
            [
                0.1737,
                1704862800
            ],
            [
                0.1739,
                1704949200
            ],
            [
                0.174,
                1705035600
            ],
            [
                0.1548,
                1705381200
            ],
            [
                0.1432,
                1705467600
            ],
            [
                0.145,
                1705554000
            ],
            [
                0.1401,
                1705640400
            ],
            [
                0.142,
                1705899600
            ],
            [
                0.1409,
                1705986000
            ],
            [
                0.1449,
                1706072400
            ],
            [
                0.1414,
                1706158800
            ],
            [
                0.15,
                1706245200
            ],
            [
                0.1515,
                1706504400
            ],
            [
                0.15,
                1706590800
            ],
            [
                0.148,
                1706677200
            ],
            [
                0.1468,
                1706763600
            ],
            [
                0.1402,
                1706850000
            ],
            [
                0.138,
                1707109200
            ],
            [
                0.12,
                1707195600
            ],
            [
                0.136,
                1707282000
            ],
            [
                0.1408,
                1707368400
            ],
            [
                0.1447,
                1707454800
            ],
            [
                0.1494,
                1707714000
            ],
            [
                0.1446,
                1707800400
            ],
            [
                0.1464,
                1707886800
            ],
            [
                0.1473,
                1707973200
            ],
            [
                0.1458,
                1708059600
            ],
            [
                0.149,
                1708405200
            ],
            [
                0.1494,
                1708491600
            ],
            [
                0.1422,
                1708578000
            ],
            [
                0.1345,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 1899,
        "drug_name": "Terlipressin",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Hepatorenal syndrome (HRS) Type 1",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-02-22",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/mallinckrodt-provides-a-regulatory-update-on-terlipressin-301486983.html",
        "note": "CRL reissued February 22, 2022. ",
        "company_entity_id": 887,
        "company_ticker": "MNKKQ",
        "company_name": "Mallinckrodt plc",
        "company_price": "0.0200",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 0,
        "company_number_of_shares": 13371707,
        "statuses": []
    },
    {
        "id": 3105,
        "drug_name": "Bardoxolone methyl",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Alport Syndrome",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-02-25",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20220225005536\/en\/",
        "note": "CRL issued February 25, 2022.",
        "company_entity_id": 333,
        "company_ticker": "RETA",
        "company_name": "Reata Pharmaceuticals Inc.",
        "company_price": "172.3600",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 1,
        "company_number_of_shares": 38150034,
        "statuses": []
    },
    {
        "id": 3105,
        "drug_name": "Bardoxolone methyl",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Alport Syndrome",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-02-25",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20220225005536\/en\/",
        "note": "CRL issued February 25, 2022.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "223.3200",
        "company_change": 0.84,
        "company_percent_change": 0.38,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                267.71,
                1704171600
            ],
            [
                263.43,
                1704258000
            ],
            [
                260.28,
                1704344400
            ],
            [
                257.88,
                1704430800
            ],
            [
                257.98,
                1704690000
            ],
            [
                255.84,
                1704776400
            ],
            [
                254.23,
                1704862800
            ],
            [
                247.21,
                1704949200
            ],
            [
                248.12,
                1705035600
            ],
            [
                246.19,
                1705381200
            ],
            [
                245.27,
                1705467600
            ],
            [
                246.97,
                1705554000
            ],
            [
                249.96,
                1705640400
            ],
            [
                248.3,
                1705899600
            ],
            [
                251.68,
                1705986000
            ],
            [
                247.16,
                1706072400
            ],
            [
                246.21,
                1706158800
            ],
            [
                244.82,
                1706245200
            ],
            [
                247.52,
                1706504400
            ],
            [
                247.08,
                1706590800
            ],
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 7752,
        "drug_name": "Lenacapavir",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "HIV",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-03-01",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20220228006261\/en\/",
        "note": "CRL announced March 1, 2022.",
        "company_entity_id": 378,
        "company_ticker": "GILD",
        "company_name": "Gilead Sciences Inc.",
        "company_price": "73.5500",
        "company_change": 0.77,
        "company_percent_change": 1.06,
        "company_optionable": 1,
        "company_number_of_shares": 1246041895,
        "price_change_sparkline": [
            [
                83.24,
                1704171600
            ],
            [
                83.48,
                1704258000
            ],
            [
                84.48,
                1704344400
            ],
            [
                83.31,
                1704430800
            ],
            [
                83.99,
                1704690000
            ],
            [
                86.06,
                1704776400
            ],
            [
                84.5,
                1704862800
            ],
            [
                85.39,
                1704949200
            ],
            [
                86.38,
                1705035600
            ],
            [
                85.99,
                1705381200
            ],
            [
                86.48,
                1705467600
            ],
            [
                86.4,
                1705554000
            ],
            [
                87.29,
                1705640400
            ],
            [
                78.43,
                1705899600
            ],
            [
                79.48,
                1705986000
            ],
            [
                79.53,
                1706072400
            ],
            [
                80.23,
                1706158800
            ],
            [
                79.52,
                1706245200
            ],
            [
                79.07,
                1706504400
            ],
            [
                78.62,
                1706590800
            ],
            [
                78.26,
                1706677200
            ],
            [
                78.16,
                1706763600
            ],
            [
                76.96,
                1706850000
            ],
            [
                76.71,
                1707109200
            ],
            [
                77.72,
                1707195600
            ],
            [
                74.42,
                1707282000
            ],
            [
                73.8,
                1707368400
            ],
            [
                73.67,
                1707454800
            ],
            [
                74.45,
                1707714000
            ],
            [
                73.53,
                1707800400
            ],
            [
                73.04,
                1707886800
            ],
            [
                73.37,
                1707973200
            ],
            [
                71.58,
                1708059600
            ],
            [
                72.04,
                1708405200
            ],
            [
                73.2,
                1708491600
            ],
            [
                72.78,
                1708578000
            ],
            [
                73.55,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5501,
        "drug_name": "FASENRA (Benralizumab) - (OSTRO)",
        "clinical_trial_id": "NCT03401229",
        "has_trial_insight_page": 0,
        "indication": "Chronic rhinosinusitis with nasal polyps (CRSwNP)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-03-14",
        "link": "https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2022\/update-on-us-review-of-fasenra-in-nasal-polyps.html",
        "note": "CRL announced March 14, 2022. ",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "65.8300",
        "company_change": 1.7,
        "company_percent_change": 2.65,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                67.3653075328265,
                1704171600
            ],
            [
                67.2865176994548,
                1704258000
            ],
            [
                67.7395592413422,
                1704344400
            ],
            [
                67.3456100744836,
                1704430800
            ],
            [
                68.1630545957153,
                1704690000
            ],
            [
                67.8675927205713,
                1704776400
            ],
            [
                68.517608845888,
                1704862800
            ],
            [
                68.1335084082009,
                1704949200
            ],
            [
                68.3698779083161,
                1705035600
            ],
            [
                66.2524011364509,
                1705381200
            ],
            [
                65.2478307609614,
                1705467600
            ],
            [
                65.513746448591,
                1705554000
            ],
            [
                65.5334439069339,
                1705640400
            ],
            [
                66.1243676572218,
                1705899600
            ],
            [
                65.7402672195347,
                1705986000
            ],
            [
                65.5925362819627,
                1706072400
            ],
            [
                66.0061829071642,
                1706158800
            ],
            [
                66.084972740536,
                1706245200
            ],
            [
                66.1736113030792,
                1706504400
            ],
            [
                66.1834600322506,
                1706590800
            ],
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6320,
        "drug_name": "Tyvyt (sintilimab) and ALIMTA (pemetrexed)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Nonsquamous NSCLC",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-03-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/74062",
        "note": "CRL announced March 24, 2022.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "769.5400",
        "company_change": -0.09999999999999998,
        "company_percent_change": -0.010000000000000009,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                591.185170245581,
                1704171600
            ],
            [
                616.641471902559,
                1704258000
            ],
            [
                613.446955616193,
                1704344400
            ],
            [
                617.490015291125,
                1704430800
            ],
            [
                624.957197110505,
                1704690000
            ],
            [
                624.408139623786,
                1704776400
            ],
            [
                629.110068282781,
                1704862800
            ],
            [
                634.630591740156,
                1704949200
            ],
            [
                641.81825338448,
                1705035600
            ],
            [
                633.482562449744,
                1705381200
            ],
            [
                627.832261768234,
                1705467600
            ],
            [
                622.281789720673,
                1705554000
            ],
            [
                627.502827276203,
                1705640400
            ],
            [
                629.798885857028,
                1705899600
            ],
            [
                628.600942249641,
                1705986000
            ],
            [
                632.614053334388,
                1706072400
            ],
            [
                626.544472390293,
                1706158800
            ],
            [
                638.154542518554,
                1706245200
            ],
            [
                643.894688970617,
                1706504400
            ],
            [
                643.874723243828,
                1706590800
            ],
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4554,
        "drug_name": "MoSEIC meloxicam-rizatriptan (AXS-07)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Migraine",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-05-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AXSM\/news\/78265",
        "note": "CRL announced May 2, 2022.",
        "company_entity_id": 61,
        "company_ticker": "AXSM",
        "company_name": "Axsome Therapeutics Inc.",
        "company_price": "78.9400",
        "company_change": -1.53,
        "company_percent_change": -1.9,
        "company_optionable": 1,
        "company_number_of_shares": 47319547,
        "price_change_sparkline": [
            [
                77.06,
                1704171600
            ],
            [
                76.09,
                1704258000
            ],
            [
                81.99,
                1704344400
            ],
            [
                82.31,
                1704430800
            ],
            [
                88.94,
                1704690000
            ],
            [
                90.43,
                1704776400
            ],
            [
                89.2,
                1704862800
            ],
            [
                86.35,
                1704949200
            ],
            [
                85.21,
                1705035600
            ],
            [
                84.95,
                1705381200
            ],
            [
                85.48,
                1705467600
            ],
            [
                84.5,
                1705554000
            ],
            [
                84.95,
                1705640400
            ],
            [
                90.92,
                1705899600
            ],
            [
                89.52,
                1705986000
            ],
            [
                91.78,
                1706072400
            ],
            [
                90.59,
                1706158800
            ],
            [
                89.84,
                1706245200
            ],
            [
                92.42,
                1706504400
            ],
            [
                91.91,
                1706590800
            ],
            [
                90.03,
                1706677200
            ],
            [
                93.45,
                1706763600
            ],
            [
                92.82,
                1706850000
            ],
            [
                91.5,
                1707109200
            ],
            [
                94.81,
                1707195600
            ],
            [
                94.02,
                1707282000
            ],
            [
                95.68,
                1707368400
            ],
            [
                96.89,
                1707454800
            ],
            [
                97.64,
                1707714000
            ],
            [
                92.26,
                1707800400
            ],
            [
                93.29,
                1707886800
            ],
            [
                93.46,
                1707973200
            ],
            [
                92.81,
                1708059600
            ],
            [
                81.14,
                1708405200
            ],
            [
                82.11,
                1708491600
            ],
            [
                80.47,
                1708578000
            ],
            [
                78.94,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5866,
        "drug_name": "ET-105 (Lamotrigine for Oral Suspension)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Lennox-Gastaut syndrome, epilepsy",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-05-27",
        "link": "https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/1710340\/000149315222015359\/form8-k.htm",
        "note": "CRL announced May 27, 2022. ",
        "company_entity_id": 611,
        "company_ticker": "ETON",
        "company_name": "Eton Pharmaceuticals Inc.",
        "company_price": "4.4700",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 1,
        "company_number_of_shares": 25658396,
        "price_change_sparkline": [
            [
                4.59,
                1704171600
            ],
            [
                4.63,
                1704258000
            ],
            [
                4.64,
                1704344400
            ],
            [
                4.34,
                1704430800
            ],
            [
                5.03,
                1704690000
            ],
            [
                4.93,
                1704776400
            ],
            [
                4.86,
                1704862800
            ],
            [
                4.74,
                1704949200
            ],
            [
                4.37,
                1705035600
            ],
            [
                4.09,
                1705381200
            ],
            [
                4.14,
                1705467600
            ],
            [
                4.08,
                1705554000
            ],
            [
                4.14,
                1705640400
            ],
            [
                4.39,
                1705899600
            ],
            [
                4.47,
                1705986000
            ],
            [
                4.45,
                1706072400
            ],
            [
                4.44,
                1706158800
            ],
            [
                4.56,
                1706245200
            ],
            [
                4.71,
                1706504400
            ],
            [
                4.74,
                1706590800
            ],
            [
                4.67,
                1706677200
            ],
            [
                4.6,
                1706763600
            ],
            [
                4.49,
                1706850000
            ],
            [
                4.58,
                1707109200
            ],
            [
                4.72,
                1707195600
            ],
            [
                4.58,
                1707282000
            ],
            [
                4.41,
                1707368400
            ],
            [
                4.41,
                1707454800
            ],
            [
                4.41,
                1707714000
            ],
            [
                4.42,
                1707800400
            ],
            [
                4.39,
                1707886800
            ],
            [
                4.59,
                1707973200
            ],
            [
                4.4,
                1708059600
            ],
            [
                4.36,
                1708405200
            ],
            [
                4.45,
                1708491600
            ],
            [
                4.47,
                1708578000
            ],
            [
                4.47,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 9499,
        "drug_name": "IMCIVREE (setmelanotide)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Alstrom Syndrome",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-06-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/RYTM\/news\/84151",
        "note": "CRL issued for sNDA application for Alstrom Syndrome issued June 16, 2022. ",
        "company_entity_id": 455,
        "company_ticker": "RYTM",
        "company_name": "Rhythm Pharmaceuticals Inc.",
        "company_price": "45.1600",
        "company_change": 1.1,
        "company_percent_change": 2.5,
        "company_optionable": 1,
        "company_number_of_shares": 59096454,
        "price_change_sparkline": [
            [
                45.13,
                1704171600
            ],
            [
                43.88,
                1704258000
            ],
            [
                43.31,
                1704344400
            ],
            [
                39.75,
                1704430800
            ],
            [
                44.5,
                1704690000
            ],
            [
                42.52,
                1704776400
            ],
            [
                42.51,
                1704862800
            ],
            [
                41.51,
                1704949200
            ],
            [
                40.68,
                1705035600
            ],
            [
                40.59,
                1705381200
            ],
            [
                41.72,
                1705467600
            ],
            [
                40.95,
                1705554000
            ],
            [
                41.04,
                1705640400
            ],
            [
                41.71,
                1705899600
            ],
            [
                42.05,
                1705986000
            ],
            [
                46.46,
                1706072400
            ],
            [
                44.18,
                1706158800
            ],
            [
                44.35,
                1706245200
            ],
            [
                44.97,
                1706504400
            ],
            [
                45.75,
                1706590800
            ],
            [
                44.11,
                1706677200
            ],
            [
                46.33,
                1706763600
            ],
            [
                44.88,
                1706850000
            ],
            [
                45.99,
                1707109200
            ],
            [
                47.64,
                1707195600
            ],
            [
                47.79,
                1707282000
            ],
            [
                47.55,
                1707368400
            ],
            [
                51.18,
                1707454800
            ],
            [
                52.44,
                1707714000
            ],
            [
                48.9,
                1707800400
            ],
            [
                50.05,
                1707886800
            ],
            [
                50.47,
                1707973200
            ],
            [
                49.23,
                1708059600
            ],
            [
                49.11,
                1708405200
            ],
            [
                48.81,
                1708491600
            ],
            [
                44.06,
                1708578000
            ],
            [
                45.16,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 1930,
        "drug_name": "Tebipenem HBr (SPR994) - (ADAPT-PO)",
        "clinical_trial_id": "NCT03788967",
        "has_trial_insight_page": 0,
        "indication": "Complicated urinary tract infections (cUTI)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-06-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SPRO\/news\/84837",
        "note": "CRL announced June 27, 2022.",
        "company_entity_id": 481,
        "company_ticker": "SPRO",
        "company_name": "Spero Therapeutics Inc.",
        "company_price": "1.5100",
        "company_change": 0.04,
        "company_percent_change": 2.7199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 52999317,
        "price_change_sparkline": [
            [
                1.52,
                1704171600
            ],
            [
                1.47,
                1704258000
            ],
            [
                1.47,
                1704344400
            ],
            [
                1.43,
                1704430800
            ],
            [
                1.41,
                1704690000
            ],
            [
                1.46,
                1704776400
            ],
            [
                1.49,
                1704862800
            ],
            [
                1.46,
                1704949200
            ],
            [
                1.45,
                1705035600
            ],
            [
                1.46,
                1705381200
            ],
            [
                1.44,
                1705467600
            ],
            [
                1.41,
                1705554000
            ],
            [
                1.39,
                1705640400
            ],
            [
                1.44,
                1705899600
            ],
            [
                1.505,
                1705986000
            ],
            [
                1.57,
                1706072400
            ],
            [
                1.56,
                1706158800
            ],
            [
                1.57,
                1706245200
            ],
            [
                1.59,
                1706504400
            ],
            [
                1.55,
                1706590800
            ],
            [
                1.52,
                1706677200
            ],
            [
                1.57,
                1706763600
            ],
            [
                1.455,
                1706850000
            ],
            [
                1.44,
                1707109200
            ],
            [
                1.48,
                1707195600
            ],
            [
                1.45,
                1707282000
            ],
            [
                1.35,
                1707368400
            ],
            [
                1.37,
                1707454800
            ],
            [
                1.5,
                1707714000
            ],
            [
                1.46,
                1707800400
            ],
            [
                1.475,
                1707886800
            ],
            [
                1.52,
                1707973200
            ],
            [
                1.53,
                1708059600
            ],
            [
                1.53,
                1708405200
            ],
            [
                1.51,
                1708491600
            ],
            [
                1.47,
                1708578000
            ],
            [
                1.51,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4132,
        "drug_name": "NUPLAZID (pimavanserin)",
        "clinical_trial_id": "NCT03325556",
        "has_trial_insight_page": 0,
        "indication": "Alzheimer\u2019s disease psychosis (ADP)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-08-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ACAD\/news\/88751",
        "note": "CRL announced August 5, 2022.",
        "company_entity_id": 5,
        "company_ticker": "ACAD",
        "company_name": "ACADIA Pharmaceuticals Inc.",
        "company_price": "24.7800",
        "company_change": -0.06999999999999995,
        "company_percent_change": -0.28,
        "company_optionable": 1,
        "company_number_of_shares": 164180377,
        "price_change_sparkline": [
            [
                30.86,
                1704171600
            ],
            [
                29.57,
                1704258000
            ],
            [
                29.95,
                1704344400
            ],
            [
                30.33,
                1704430800
            ],
            [
                30.13,
                1704690000
            ],
            [
                30.66,
                1704776400
            ],
            [
                29.3,
                1704862800
            ],
            [
                28.8,
                1704949200
            ],
            [
                28.73,
                1705035600
            ],
            [
                28.95,
                1705381200
            ],
            [
                27.98,
                1705467600
            ],
            [
                27.59,
                1705554000
            ],
            [
                27.29,
                1705640400
            ],
            [
                27.76,
                1705899600
            ],
            [
                28.15,
                1705986000
            ],
            [
                27.19,
                1706072400
            ],
            [
                27.17,
                1706158800
            ],
            [
                26.94,
                1706245200
            ],
            [
                27.54,
                1706504400
            ],
            [
                26.83,
                1706590800
            ],
            [
                25.91,
                1706677200
            ],
            [
                26.14,
                1706763600
            ],
            [
                25.29,
                1706850000
            ],
            [
                25.1,
                1707109200
            ],
            [
                25.74,
                1707195600
            ],
            [
                25.21,
                1707282000
            ],
            [
                25.68,
                1707368400
            ],
            [
                26.36,
                1707454800
            ],
            [
                26.76,
                1707714000
            ],
            [
                25.56,
                1707800400
            ],
            [
                25.56,
                1707886800
            ],
            [
                25.18,
                1707973200
            ],
            [
                25.11,
                1708059600
            ],
            [
                24.85,
                1708405200
            ],
            [
                24.87,
                1708491600
            ],
            [
                24.85,
                1708578000
            ],
            [
                24.78,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6977,
        "drug_name": "SPN-830",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Motor fluctuations in Parkinson\u2019s disease (PD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-10-10",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SUPN\/news\/96370",
        "note": "CRL announced October 10, 2022.",
        "company_entity_id": 287,
        "company_ticker": "SUPN",
        "company_name": "Supernus Pharmaceuticals Inc.",
        "company_price": "29.0600",
        "company_change": 1.13,
        "company_percent_change": 4.03,
        "company_optionable": 1,
        "company_number_of_shares": 54632847,
        "price_change_sparkline": [
            [
                27.73,
                1704171600
            ],
            [
                27.81,
                1704258000
            ],
            [
                27.74,
                1704344400
            ],
            [
                27.43,
                1704430800
            ],
            [
                27.81,
                1704690000
            ],
            [
                28.32,
                1704776400
            ],
            [
                28.14,
                1704862800
            ],
            [
                27.72,
                1704949200
            ],
            [
                28.24,
                1705035600
            ],
            [
                28.47,
                1705381200
            ],
            [
                27.91,
                1705467600
            ],
            [
                27.52,
                1705554000
            ],
            [
                27.67,
                1705640400
            ],
            [
                28.41,
                1705899600
            ],
            [
                27.72,
                1705986000
            ],
            [
                28.07,
                1706072400
            ],
            [
                28.85,
                1706158800
            ],
            [
                28.72,
                1706245200
            ],
            [
                29.07,
                1706504400
            ],
            [
                28.35,
                1706590800
            ],
            [
                27.68,
                1706677200
            ],
            [
                27.86,
                1706763600
            ],
            [
                27.67,
                1706850000
            ],
            [
                27.31,
                1707109200
            ],
            [
                28.31,
                1707195600
            ],
            [
                27.24,
                1707282000
            ],
            [
                27.9,
                1707368400
            ],
            [
                27.91,
                1707454800
            ],
            [
                28.35,
                1707714000
            ],
            [
                27.11,
                1707800400
            ],
            [
                27.56,
                1707886800
            ],
            [
                28.66,
                1707973200
            ],
            [
                28.42,
                1708059600
            ],
            [
                28.05,
                1708405200
            ],
            [
                28.14,
                1708491600
            ],
            [
                27.935,
                1708578000
            ],
            [
                29.06,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5794,
        "drug_name": "Omburtamab",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "CNS\/Leptomeningeal Metastases from Neuroblastoma",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2022-12-01",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/YMAB\/news\/102928",
        "note": "CRL issued by FDA on December 1, 2022.",
        "company_entity_id": 658,
        "company_ticker": "YMAB",
        "company_name": "Y-mAbs Therapeutics Inc.",
        "company_price": "16.5100",
        "company_change": -0.5,
        "company_percent_change": -2.94,
        "company_optionable": 1,
        "company_number_of_shares": 43621618,
        "price_change_sparkline": [
            [
                6.87,
                1704171600
            ],
            [
                6.57,
                1704258000
            ],
            [
                6.85,
                1704344400
            ],
            [
                7.18,
                1704430800
            ],
            [
                7.77,
                1704690000
            ],
            [
                7.19,
                1704776400
            ],
            [
                7.18,
                1704862800
            ],
            [
                7.53,
                1704949200
            ],
            [
                9.65,
                1705035600
            ],
            [
                9.59,
                1705381200
            ],
            [
                9.83,
                1705467600
            ],
            [
                9.68,
                1705554000
            ],
            [
                9.38,
                1705640400
            ],
            [
                9.77,
                1705899600
            ],
            [
                9.75,
                1705986000
            ],
            [
                9.49,
                1706072400
            ],
            [
                10.54,
                1706158800
            ],
            [
                11.27,
                1706245200
            ],
            [
                12.11,
                1706504400
            ],
            [
                12.54,
                1706590800
            ],
            [
                12.79,
                1706677200
            ],
            [
                13.39,
                1706763600
            ],
            [
                14,
                1706850000
            ],
            [
                13.67,
                1707109200
            ],
            [
                13.59,
                1707195600
            ],
            [
                13.05,
                1707282000
            ],
            [
                12.97,
                1707368400
            ],
            [
                13.11,
                1707454800
            ],
            [
                14.36,
                1707714000
            ],
            [
                14.88,
                1707800400
            ],
            [
                15.2,
                1707886800
            ],
            [
                16,
                1707973200
            ],
            [
                16.29,
                1708059600
            ],
            [
                16.55,
                1708405200
            ],
            [
                16.47,
                1708491600
            ],
            [
                17.01,
                1708578000
            ],
            [
                16.51,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 7335,
        "drug_name": "Donanemab",
        "clinical_trial_id": "NCT04437511",
        "has_trial_insight_page": 1,
        "indication": "Alzheimer's Disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2023-01-20",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/111730",
        "note": "CRL received for accelerated approval application, noted January 20, 2023.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "769.5400",
        "company_change": -0.09999999999999998,
        "company_percent_change": -0.010000000000000009,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                591.185170245581,
                1704171600
            ],
            [
                616.641471902559,
                1704258000
            ],
            [
                613.446955616193,
                1704344400
            ],
            [
                617.490015291125,
                1704430800
            ],
            [
                624.957197110505,
                1704690000
            ],
            [
                624.408139623786,
                1704776400
            ],
            [
                629.110068282781,
                1704862800
            ],
            [
                634.630591740156,
                1704949200
            ],
            [
                641.81825338448,
                1705035600
            ],
            [
                633.482562449744,
                1705381200
            ],
            [
                627.832261768234,
                1705467600
            ],
            [
                622.281789720673,
                1705554000
            ],
            [
                627.502827276203,
                1705640400
            ],
            [
                629.798885857028,
                1705899600
            ],
            [
                628.600942249641,
                1705986000
            ],
            [
                632.614053334388,
                1706072400
            ],
            [
                626.544472390293,
                1706158800
            ],
            [
                638.154542518554,
                1706245200
            ],
            [
                643.894688970617,
                1706504400
            ],
            [
                643.874723243828,
                1706590800
            ],
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    }
]

